Rapidly fatal acanthamoeba encephalitis and treatment of cryoglobulinemia

Emerging Infectious Diseases

Volumn 13, Issue 3, 2007, Pages 469-471

  Meersseman, Wouter ^a   Lagrou, Katrien ^a   Sciot, Raf ^a   De Jonckheere, Johan ^b   Haberler, Christine ^c   Walochnik, Julia ^c   Peetermans, Willy E ^a   Van Wijngaerden, Eric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; RITUXIMAB;

ACANTHAMOEBA; AGED; ARTICLE; AUTOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIAGNOSTIC IMAGING; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGOENCEPHALITIS; NEUROIMAGING; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PROTOZOAL INFECTION;

EID: 33847343993     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1303.061001     Document Type: Article

References (14)

1. Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol. 2004;34:1001-27.
2. Eisenberg R. Update on rituximab. Ann Rheum Dis. 2005;64(Suppl 4):iv55-7.
3. Foreman O, Sykes J, Ball L, Yang N, de Cock H. Disseminated infection with Balamuthia mandrillaris in a dog. Vet Pathol. 2004;41:506-10.
4. Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol. 2005;43:1689-93.
5. Cerva L. Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man. J Hyg Epidemiol Microbiol Immunol. 1989;33:99-103.
6. Chappell CL, Wright JA, Coletta M, Newsome AL. Standardized methods of measuring Acanthamoeba antibodies in sera from healthy human subjects. Clin Diagn Lab Immunol. 2001;8:724-30.
7. Schuster FL, Honarmand S, Visvesvara GS, Glaser CA. Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Clin Infect Dis. 2006;42:1260-5.
8. Shirwadkar CG, Samant R, Sankhe M, Deshpande R, Yagi S, Schuster FL, et al. Acanthamoeba encephalitis in patient with systemic lupus, India. Emerg Infect Dis. 2006;12:984-6.
9. Zaja F, de Vita S, Mazzaro C, Sacco S, Damiani D, de Marchi G, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-34.
10. Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol. 2003;30(Suppl 2):3-8.
11. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood. 2000;96:1184-6.
12. Dervite I, Hober D, Morel P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med. 2001;344:68-9.
13. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med. 2001;345:1000.
14. Bermudez A, Marco F, Conde E, Mazo E, Recio M, Zubizarreta A. Fatal visceral varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma. Haematologica. 2000;85:894-5.